Christopher Gromala v. HHS - Influenza, Guillain-Barré syndrome (GBS) and a subset of AIDP [acute inflammatory demyelinating polyneuropathy] which evolved into CIDP [chronic inflammatory demyelinating polyneuropathy] (2023)
Case summary [AI summaries can sometimes make mistakes]
Christopher Gromala alleged that the influenza vaccine administered on October 4, 2016, caused him to suffer from Guillain-Barré syndrome (GBS) and related conditions, which evolved into chronic inflammatory demyelinating polyneuropathy (CIDP). He filed a petition for compensation with the Court of Federal Claims on August 21, 2019.
The case involved the submission of medical records and expert reports from both petitioner and respondent. After reviewing the evidence, the Special Master issued a tentative finding denying entitlement, noting difficulties in establishing a definitive diagnosis and satisfying the legal requirements for causation.
Subsequently, Mr. Gromala moved to dismiss his own petition, understanding that this would result in a judgment against him and end his rights in the Vaccine Program.
The Secretary of Health and Human Services did not oppose the motion. The Special Master granted the motion, dismissing the case with prejudice due to insufficient proof.
No compensation was awarded.
Source PDFs
USCOURTS-cofc-1_19-vv-01247